| Patents for A61P 11 - Drugs for disorders of the respiratory system (87,767) |
|---|
| 02/08/2006 | CN1731999A Benzothiazole derivatives |
| 02/08/2006 | CN1731932A Methods of diagnosis and treatment of interstitial lung disease |
| 02/08/2006 | CN1730086A Paste for treating cough and asthma and process for preparing the same |
| 02/08/2006 | CN1730079A Chinese traditional medicine for treating asthma |
| 02/08/2006 | CN1730078A Pharynx clearing tea |
| 02/08/2006 | CN1730077A Chinese traditional medicine preparation for curing laryngopharyngitis |
| 02/08/2006 | CN1730071A Purple perilla capsule and process for preparing the same |
| 02/08/2006 | CN1730070A Compound lindley eupatorium herb powder and preparation process thereof |
| 02/08/2006 | CN1730068A Medicinal powder for treating asthma and cough |
| 02/08/2006 | CN1730065A Medicament for treating rhinitis |
| 02/08/2006 | CN1730059A Inflammation diminishing capsule and its preparing process |
| 02/08/2006 | CN1730053A Process for preparing chewing tablet of 'Qingkailing' |
| 02/08/2006 | CN1730052A Cape jasmine and baikal skullcap root di-glycocide injection and its preparation process and purposes |
| 02/08/2006 | CN1730042A Process for preparing 'Yiqing' dripping pills |
| 02/08/2006 | CN1730034A Pharmaceutical composition for treating acute pneumonia, urinary tract infection and cholecystitis |
| 02/08/2006 | CN1730033A Soft capsule for treating rhinitis and its preparing process |
| 02/08/2006 | CN1730014A Novel drug administration route of semen armeniacae amarum injection, its preparation process and new indications |
| 02/08/2006 | CN1730006A Pharmaceutical composition for treating lung and kidney deficiency and qi, yin insufficiency and preparation method thereof |
| 02/08/2006 | CN1730005A Method for preparing dripping pills of ganoderma lucidum |
| 02/08/2006 | CN1240684C Dibenzocycloheptene compound |
| 02/08/2006 | CN1240681C Nitrile derivatives as cathepsin K inhibitors |
| 02/08/2006 | CN1240404C Chinese herbal medicine prescription for prevention and treatment of atypical pneumonia |
| 02/08/2006 | CN1240400C Supercritical extraction process of producing cordyceps oil |
| 02/08/2006 | CN1240392C Agent for promoting cell activation for external use |
| 02/07/2006 | US6995272 Crystal form of N-(4-trifluoromethylphenyl)-5-methylisoxazole-4-carboxamide |
| 02/07/2006 | US6995186 For therapy of allergic or inflammatory disorders of the eye and nose |
| 02/07/2006 | US6995184 Such as (7-chloro-2-methyl-1-(3-(methylsulphanyl)propyl)-1H-indol-3-yl)(2,3-dichloro-phenyl)methanone; cannabinoid receptors (cb2); G proteins coupled receptors |
| 02/07/2006 | US6995163 having an excellent corticotrophin-releasing-factor receptor antagonistic activity; for treating or preventing depression, nerve system disorders, schizophrenia, peptic ulcer, irritable bowel syndrome |
| 02/07/2006 | US6995162 Substituted alkylamine derivatives and methods of use |
| 02/07/2006 | US6995153 tachykinin receptor antagonist, in particular, an NK1 receptor antagonist; prophylactic or therapeutic agent against tachykinin receptor-related pathological conditions, including increased urinary frequency, incontinence, vomiting, inflammation |
| 02/07/2006 | US6994977 Combining a compound to be tested, a host cell expressing a recombinant protein containing a mammalian C-C chemokine receptor 3 and a ligand for binding of ligand to such receptor, detecting the formation of a receptor-ligand complex |
| 02/07/2006 | US6994857 A Therapeutic protein (e.g., a polypeptide, antibody, or peptide, or fragments and variants) fused to albumin, is sufficient to prolong the shelf-lilfe of therapeutic protein |
| 02/07/2006 | CA2340202C Hydroxy pipecolate hydroxamic acid derivatives as mmp inhibitors |
| 02/07/2006 | CA2311344C 5-(2-imidazolinylamino)-benzimidazole derivatives, their preparation and their use as .alpha.-adrenoceptor agonists with improved metabolic stability |
| 02/07/2006 | CA2273479C 6-phenylpyridyl-2-amine derivatives useful as nos inhibitors |
| 02/02/2006 | WO2006011466A1 5-substituted-2-phenylamino-benzamide as mek inhibitor |
| 02/02/2006 | US20060025597 4-(Aminomethyl)-2-(2,6-dioxo(3-piperidyl))isoindoline-1,3-dione hydrochloride; cytokines level reduced; tumor necrosis factor inhibitors; nontoxic; anticarcinogenic agents; antitumor agents (solid/blood-borne); cardiovascular disorders; osteoporosis; antiinflammatory agents; autoimmune diseases |
| 02/02/2006 | US20060025432 N-[2-[(3-Chloro-2-fluorobenzyl)thio]-6-[(2-hydroxy-1-methylethyl)amino]-4-pyrimidinyl]- 4-morpholinesulfonamide; asthma, antiallergens; rhinitis, chronic obstructive pulmonary disease, inflammatory bowel disease, irritable bowel syndrome, osteoarthritis, osteoporosis, rheumatoid arthritis, psoriasis |
| 02/02/2006 | US20060025428 Bicyclic heteroaromatic compounds as kinase inhibitors |
| 02/02/2006 | US20060025423 2,3-Dichloro-N-(3-methoxy-5-methyl-2-pyrazinyl)-benzenesulphonamide; inflammatory diseases, such as asthma |
| 02/02/2006 | US20060025410 2,4-Pyrimidinediamine compounds and their uses |
| 02/02/2006 | US20060025404 Such as 1-(4-{[1-(1-methylethyl)-4-piperidinyl]oxy}phenyl)-4-{[4-(methylsulfonyl)phenyl]carbonyl}piperazine; neurodegenerative disorders including Alzheimer's disease; allergic rhinitis |
| 02/02/2006 | US20060025403 Compounds useful as modulators of melanocortin receptors and pharmaceutical compositions comprising same |
| 02/02/2006 | US20060025392 Combination medicament |
| 02/02/2006 | US20060025391 Combination of azelastine and steroids |
| 02/02/2006 | US20060025374 Novel oligoribonucleotide derivatives for specific inhibition of gene expression |
| 02/02/2006 | US20060025326 Method for treating carrier particles and its use |
| 02/02/2006 | US20060024792 G-protein coupled receptors |
| 02/02/2006 | US20060024293 Antibody for use in the treatment and prevention of sepsis, infections, autoimmune and graft-versus-host diseases; biodegradable, biocompatible polymer and human antibody, or an antigen-binding portion thereof, that dissociates from human TNF alpha |
| 02/02/2006 | US20060024267 TNFr/OPG-like molecules and uses thereof |
| 02/01/2006 | EP1621540A1 Nitrogen-containing heterocyclic compounds and use thereof |
| 02/01/2006 | EP1621197A2 Composition comprising a steroid and an anticholinergic agent |
| 02/01/2006 | EP1621195A2 The use of pyridinic NK-1 receptor antagonists for the treatment of brain, spinal or nerve injury |
| 02/01/2006 | EP1621191A1 Treatment of inflammatory diseases by RXR Antagonists |
| 02/01/2006 | EP1620556A1 Nucleic acid detection |
| 02/01/2006 | EP1620089A1 Therapeutic and prophylactic compositions and uses therefor |
| 02/01/2006 | EP1620087A1 Azabicyclo derivatives as muscarinic receptor antagonists |
| 02/01/2006 | EP1463707A4 A group of novel anti-cancer compounds with specific structure |
| 02/01/2006 | EP1425281B1 Tricyclic CRF receptor antagonists |
| 02/01/2006 | EP1343492B1 Treatment of mucositis |
| 02/01/2006 | EP1235812B1 Pyrimidine derivatives as selective inhibitors of cox-2 |
| 02/01/2006 | EP1158968B1 Jak-3 inhibitors for treating allergic disorders |
| 02/01/2006 | EP1133315B1 Antagonists of the alpha e beta 7 integrin as therapeutic agents for inflammatory diseases |
| 02/01/2006 | EP1131302B1 Substituted 4-amino-2-aryl-cyclopenta [d]pyrimidines, their production and use and pharmaceutical preparations containing the same |
| 02/01/2006 | EP1080078B1 Heterocyclic compounds and methods to treat cardiac failure and other disorders |
| 02/01/2006 | EP0835313B1 Omp26 antigen from haemophilus influenzae |
| 02/01/2006 | EP0759297B1 Remedy for pulmonary heart |
| 02/01/2006 | CN2754631Y Straw for drinking kechuanting |
| 02/01/2006 | CN1729192A Optical resolution of (1-benzyl-4-methylpiperidin-3-yl) -methylamine and the use thereof for the preparation of pyrrolo 2,3-pyrimidine derivatives as protein kinases inhibitors |
| 02/01/2006 | CN1728988A Powdered medicaments containing a tiotropium salt and salmeterol xinafoate |
| 02/01/2006 | CN1726984A Chinese materia medica preparation for strengthening the spleen, eliminating dampness, expelling phlegm and relieving a cough, and preparation method |
| 02/01/2006 | CN1726979A Sustained release preparation of root of indian stringbush |
| 02/01/2006 | CN1726961A Essential oils for treating and/or preventing allergic disease |
| 02/01/2006 | CN1726940A Chinese materia medica preparation for relieving a cough, eliminating sputum and preventing asthma, and preparation method |
| 02/01/2006 | CN1726921A Oral preparation of prostaglandin E1 |
| 02/01/2006 | CN1726920A Nose taking powder of prostaglandin E |
| 02/01/2006 | CN1726915A Nasal cavity taken drug system and combination of naloxone hydrochloride and preparation method |
| 02/01/2006 | CN1239498C Substituted pyrrolidines as CCR-3 receptor antagonists |
| 02/01/2006 | CN1239485C Benzophenones as inhibitors of IL-1 beta and TNF-alpha |
| 02/01/2006 | CN1239190C Chinese traditional medicine particle for treating pulmonary heart disease |
| 02/01/2006 | CN1239188C Use of Chinese medicine composition in preparing medicine for anti SARS virus |
| 02/01/2006 | CN1239178C Method for preparing qingkailing granules |
| 02/01/2006 | CN1239160C Hormone replacement therapy |
| 01/31/2006 | US6992192 preferential inhibitors of cyclic guanosine 3',5'-monophosphate specific phosphodiesterase used for prophylaxis of erectile dysfunction and cardiovascular disorders |
| 01/31/2006 | US6992189 Such as 4-((Z)-(4-bromophenyl)(ethoxyimno)methyl)-1'-((2,4-dimethyl-1-oxido-3-pyridinyl)carbonyl)-4'-methyl-1,4'-bipiperidine; for the treatment of AIDS and related HIV infections |
| 01/31/2006 | US6992086 Antagonists of MCP-1 function and methods of use thereof |
| 01/31/2006 | US6992084 Compounds and methods for modulating CXCR3 function |
| 01/31/2006 | US6992078 Solvent extraction, separation, crystallization |
| 01/31/2006 | CA2327498C Process for alkylating hindered sulfonamides useful in the production of matrix metalloproteinase inhibitors |
| 01/31/2006 | CA2314154C Azepine or larger medium ring derivatives and their use as pharmaceuticals |
| 01/31/2006 | CA2224635C Pyridine derivatives, process for preparing the same, and intermediate therefor |
| 01/31/2006 | CA2208839C Quinuclidine derivatives and medicinal composition thereof |
| 01/26/2006 | WO2006009209A1 Preventive or therapeutic agent for chronic inflammatory lung disease |
| 01/26/2006 | WO2006009114A1 Il-18 receptor antagonist and pharmaceutical composition containing the antagonist |
| 01/26/2006 | WO2006009092A1 Method of effectively using medicine and method concerning prevention of side effect |
| 01/26/2006 | WO2006007881A2 New pharmaceutical compositions based on fluorenecarboxyclic acid esters and soluble tnf receptor fusion proteins |
| 01/26/2006 | WO2005118579A3 Thiazole derivatives as chemokine receptor antagonists |
| 01/26/2006 | US20060020138 E.g., 3-arylmethyl-7-hydroxy-coumarins as intermediates; affects both the Tumor Necrosis Factor alpha level and transcription activity of NuclearFactor kappa Beta; antiimmunoinflammatory agents and autoimmune properties; antiarthritis agents; rheummatic diseases; osteoporosis; leukemia |
| 01/26/2006 | US20060020046 Compositions comprising lycopene for the treatment and prevention of angiogenesis associated pathologies |
| 01/26/2006 | US20060019999 Specific inhibitors of one or more isoforms of nitric oxide synthase; 3-[[2-amino-1-phenylethyl]thio]-5-methyl-2-thiophenecarbonitrile; antiinflammatory agent; pain |